Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3709958011 | Product containing felbinac in transdermal dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3709959015 | Felbinac-containing product in transdermal dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Felbinac-containing product in transdermal dose form | Is a | Felbinac-containing product | true | Inferred relationship | Some | ||
| Felbinac-containing product in transdermal dose form | Is a | Product manufactured as transdermal dose form | true | Inferred relationship | Some | ||
| Felbinac-containing product in transdermal dose form | Has active ingredient | Felbinac | true | Inferred relationship | Some | 1 | |
| Felbinac-containing product in transdermal dose form | Has manufactured dose form | Transdermal dose form | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Felbinac only product in transdermal dose form | Is a | True | Felbinac-containing product in transdermal dose form | Inferred relationship | Some | |
| Felbinac 30 mg/g transdermal gel | Is a | False | Felbinac-containing product in transdermal dose form | Inferred relationship | Some | |
| Felbinac 31.7 mg/g transdermal foam | Is a | False | Felbinac-containing product in transdermal dose form | Inferred relationship | Some |
Reference Sets
Description inactivation indicator reference set
FHIR